Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04679532 · ClinicalTrials.gov registry record · NA

NBA G-League Sweat Testing Study: Validity of the Gx Sweat Patch in Measuring Sweating Rate and Sweat Chloride Concentration During On-court Training With Basketball Players

A NA study, sponsored by PepsiCo Global R&D.

Completed
Registry status
NA
Development phase
65
Enrollment target

NCT04679532 is a NA study that has completed, run by PepsiCo Global R&D. The registered enrollment target is 65 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04679532, a NA study, has completed, sponsored by PepsiCo Global R&D.

COMPLETED
Registry status
NA
Development phase
65 participants
Enrollment target

Study Summary

To determine the validity of the Gx Sweat Patch in measuring sweating rate and sweat chloride concentration during moderate-high intensity practice against well-established reference methods in field conditions with basketball athletes

Interventions

  • OTHER Gx sweat patch
  • OTHER Reference sweat patch

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2020-12-08
Est. Completion 2021-11-04
Phase NA

Sponsor

PepsiCo Global R&D

47 total trials

What the Registry Record Tells You About NCT04679532

The ClinicalTrials.gov registry entry for NCT04679532 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PepsiCo Global R&D, which has 47 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Gx sweat patch is the first listed.

NCT04679532 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04679532 about?

NCT04679532 is a clinical study titled "NBA G-League Sweat Testing Study: Validity of the Gx Sweat Patch in Measuring Sweating Rate and Sweat Chloride Concentration During On-court Training With Basketball Players". To determine the validity of the Gx Sweat Patch in measuring sweating rate and sweat chloride concentration during moderate-high intensity practice against well-established reference methods in field conditions with basketball athletes

What is the current status of trial NCT04679532?

This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2020-12-08. Estimated completion is 2021-11-04.

What interventions are being tested in trial NCT04679532?

The interventions under investigation include: Gx sweat patch (OTHER), Reference sweat patch (OTHER).

Who is sponsoring clinical trial NCT04679532?

This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.